SAB Diagnostics
ActiveSummary
SAB Diagnostics has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,010 and a net result of €124,583. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 610 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2022 to 2025net €124,583 ▲2.2%
Operating result €160,473, net result €124,583, both a record.
12-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
14-11
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 13-08-2024
- Registered-office move, Avenue Paul Hymans 124 boîte 31 - 1200 Woluwe-Saint-Lambert
14-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Liquidity more than doubledcurrent ratio 6.61
Current ratio from 2.62 to 6.61; short-term debt falls from €43,950 to €27,934.
31-12
Financial
Equity above €150,000equity €159,362 ▲101%
A profit in every financial year since 2022 builds equity to €159,362.
22-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.